Robert McDowell
Keine laufenden Positionen mehr
Karriereverlauf von Robert McDowell
Ehemalige bekannte Positionen von Robert McDowell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MYOKARDIA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2017 | 01.11.2020 |
Corporate Officer/Principal | 01.07.2012 | 01.10.2017 | |
SAGIMET BIOSCIENCES INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.05.2010 | 01.07.2012 |
Corporate Officer/Principal | 08.02.2010 | 14.05.2010 | |
VIRACTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2000 | 04.08.2008 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1999 | 01.01.2000 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1988 | 01.01.1999 |
Ausbildung von Robert McDowell
Butler University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SAGIMET BIOSCIENCES INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Robert McDowell
- Erfahrung